Barza M, McCue M
Antimicrob Agents Chemother. 1983 Oct;24(4):468-73. doi: 10.1128/AAC.24.4.468.
Subconjunctival injection of 100 mg of aztreonam in rabbits with Pseudomonas aeruginosa endophthalmitis produced transiently high antibiotic concentrations in most intraocular sites. Concentrations of approximately 2.5 micrograms/ml were achieved in the vitreous humor 15 min after injection and persisted for 6 h. Repeated intramuscular injections in dosages of 25 mg/kg every 4 h resulted in drug concentrations in the vitreous humor of 2.4 micrograms/ml in infected eyes. These levels might be adequate for the treatment of intraocular infections caused by highly susceptible organisms. Direct intravitreal injection of 100 micrograms of aztreonam in normal rabbit eyes produced an estimated peak concentration in the vitreous humor of 62 micrograms/ml, with a half-life of 7.5 h, which declined to 6 micrograms/ml by 48 h. The pharmacokinetic indices suggest that, like other beta-lactam antibiotics, aztreonam is eliminated from the vitreous humor by the retinal route. This novel antibiotic warrants further study of its efficacy and toxicity to determine whether it may be a useful alternative to the aminoglycosides for selected cases of ocular infection.
在患有铜绿假单胞菌性眼内炎的兔子中,结膜下注射100毫克氨曲南可在大多数眼内部位产生短暂的高抗生素浓度。注射后15分钟,玻璃体液中达到约2.5微克/毫升的浓度,并持续6小时。每4小时重复肌肉注射25毫克/千克的剂量,感染眼中玻璃体液中的药物浓度为2.4微克/毫升。这些水平可能足以治疗由高度敏感菌引起的眼内感染。在正常兔眼中直接玻璃体内注射100微克氨曲南,玻璃体液中的估计峰值浓度为62微克/毫升,半衰期为7.5小时,到48小时时降至6微克/毫升。药代动力学指标表明,与其他β-内酰胺类抗生素一样,氨曲南通过视网膜途径从玻璃体液中消除。这种新型抗生素的疗效和毒性值得进一步研究,以确定它是否可能成为某些眼部感染病例中氨基糖苷类药物的有用替代品。